These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 5537801)
21. Study dispels assumptions about adverse drug events. Rollins G Rep Med Guidel Outcomes Res; 2001 Aug; 12(17):1-2, 5. PubMed ID: 12296363 [No Abstract] [Full Text] [Related]
22. From a malpractice lawyer's case book. Med Times; 1971 Aug; 99(8):81 passim. PubMed ID: 5566829 [No Abstract] [Full Text] [Related]
23. Physicians' liability for failure to anticipate and control reactions and interactions precipitated by prescribed or administered drugs. Junewicz JJ Leg Med Annu; 1977; 1976():327-49. PubMed ID: 865226 [No Abstract] [Full Text] [Related]
24. Drug reactions: the role of the package insert. Barnett FJ J Leg Med (N Y); 1973; 1(1):19-23. PubMed ID: 4548069 [No Abstract] [Full Text] [Related]
25. Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; revision of certain labeling controls--FDA. Final rule. Fed Regist; 1993 Aug; 58(147):41348-54. PubMed ID: 10127711 [TBL] [Abstract][Full Text] [Related]
27. On the accountability problem of the pharmaceutical industry. Roberts CD Pharmazie; 1973 Jan; 28(1):49-51. PubMed ID: 4714241 [No Abstract] [Full Text] [Related]
28. Are drugs approved by the FDA safe and risk free? Natl Med Leg J; 1991; 2(1):8. PubMed ID: 2018814 [TBL] [Abstract][Full Text] [Related]
29. Medical costs and the drug industry. Schwartz H Med Times; 1981 Mar; 109(3):21s-24s, 28s. PubMed ID: 7207081 [No Abstract] [Full Text] [Related]
31. Implications of drug reactions--recognition, incidence and prevention. Cooper JW R I Med J (1974); 1975 Jun; 58(6):274-80, 287-8. PubMed ID: 124935 [No Abstract] [Full Text] [Related]
32. Black box warnings in prescription drug labeling: results of a survey of 206 drugs. Beach JE; Faich GA; Bormel FG; Sasinowski FJ Food Drug Law J; 1998; 53(3):403-11. PubMed ID: 10346718 [No Abstract] [Full Text] [Related]
33. Patient package inserts--instructions or intrusions? Harvey MW Leg Aspects Med Pract; 1978 Aug; 6(8):47-51. PubMed ID: 703481 [No Abstract] [Full Text] [Related]
34. "Safer, but not safe enough". Crombie HD Conn Med; 2006; 70(10):645. PubMed ID: 17190395 [No Abstract] [Full Text] [Related]
35. The medicolegal significance of the package insert. Hirsh HL Conn Med; 1978 Dec; 42(12):785-8. PubMed ID: 720048 [No Abstract] [Full Text] [Related]
36. Food and Drug Administration's adverse drug reaction monitoring program. Lee B; Turner WM Am J Hosp Pharm; 1978 Aug; 35(8):929-32. PubMed ID: 677138 [TBL] [Abstract][Full Text] [Related]
37. Physicians, pharmacists, pharmaceutical manufacturers: partners in patient care, partners in litigation? Willig SH Spec Law Dig Health Care (Mon); 1987 Feb; 8(12):7-40. PubMed ID: 10280590 [No Abstract] [Full Text] [Related]
38. [The medical expert and therapeutic drug pathology]. Radian IS Acta Med Leg Soc (Liege); 1967; 20(2):153-7. PubMed ID: 5634310 [No Abstract] [Full Text] [Related]
39. [Adverse drug reactions and professional indemnity insurance]. Sicot C Bull Acad Natl Med; 2005 Nov; 189(8):1735-41. PubMed ID: 16737098 [TBL] [Abstract][Full Text] [Related]
40. Urgent--drug recall. How well does the system work? Small WE Am Pharm; 1980 Aug; NS20(8):17-9. PubMed ID: 7424773 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]